Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With an acute shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.

In a statement, the MD and Chairman Dr. D Srinivasa Reddy had declared that Optimus pharma has internally developed the active pharmaceutical ingredient (API) and the formulations for the product and had obtained approval for conducting Phase 3 Clinical Trial.

As per the clinical trial protocol approved, 1218 subjects with mild COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with the standard of care, or standard of care alone. The treatment duration is a maximum of 05 days and the total study duration will be a maximum of 28 days from randomisation.

“Optimus is all geared to immediately begin manufacturing of Molnupiravir for COVID-19 patients in India. The interim results on 353 patients have shown promising results of Molnupiravir. The drug has been successful in reducing viral load effectively with RT-PCR negativity achieved 78.3 % in the test arm compared to 48.4% in the standard of care arm on Day 5. Day 10 and Day 14 of the treatment duration have also given excellent results wherein the remaining patients have successfully achieved RT-PCR negativity. The trial has also revealed clinical improvement in a significantly high proportion of patient’s health. The safety of the drug has also been established with no observed side effects, co-morbidity, or morbidity observed during and after the treatment duration,” Chairman & Managing Director – Dr. D Srinivasa Reddy said.

Optimus has approached the Drugs Controller General of India (DCGI) to seek Emergency Use Authorization for Molnupiravir in India.

Optimus Pharma is committed to serve the nation and fight back the pandemic to restore normalcy in the lives of people affected by COVID-19 at the earliest. With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Subhash Ghai, Rakeysh Mehra, Jackie Shroff, Divya Dutta and Ravinder Bhakar celebrate 75th Independence Day hosted by National Museum of Indian Cinema

Read Time:2 Minute, 43 Second New Delhi,  August 15: National Museum of Indian Cinema hosted Filmmakers Rakeysh Omprakash Mehra and Subhash Ghai, along with Actors Jackie Shroff and Divya Dutta, for a flag hoisting ceremony on India’s 75th Independence Day celebration. Also present at the occasion were producer Shabbir Boxwala and screenwriter Sandeep Shrivastava. A […]

Read More
National

KP Human organized Tiranga Samman Yatra, Surat witnesses communal harmony

Read Time:1 Minute, 54 Second More than 30,000 people, the majority of them Muslims, participate in the massive yatra organised by KP Human Development Foundation. Surat (Gujarat) [India], August 15: The Diamond City of Surat witnessed a unique Tiranga Samman Yatra. Organised by KP Human Development Foundation, the massive yatra commenced after the Friday afternoon […]

Read More
National

Delhi Based Personalities Celebrates The Spirit Of Independence Day

Read Time:2 Minute, 5 Second Participates in the campaign Har Ghar Tiranga August 13: Though a week to go, the entire country will soak in the celebrations of 75th Independence Day, but already Delhi-based personalities have started the celebrations. To encourage people to bring the Tiranga home and hoist it to mark the 75th year […]

Read More